Search Results - momar+ndao

3 Results Sort By:
Use of Schistosoma mansoni Cathepsin B (antigen) and Addavax (adjuvant) as vaccine to protect from Schistosomiasis
NOVEL VACCINE AGAINST SCHISTOSOMIASIS A powerful combination of vaccine targeting Schistosoma mansoni cathepsin B with Addavax adjuvant results in highly efficient immunization against the parasite Source: CDC UNMET NEED Schistosomiasis affects over 200 million people worldwide and has a significant economic burden (~$50 billion US), especially...
Published: 12/3/2025   |   Inventor(s): Dilhan Perera, Momar Ndao
Keywords(s): Innovation
Category(s): Secteurs > Sciences de la vie, Sectors > Life sciences, Applications > Soins et santé > Traitement, Applications > Soins et santé > Prévention, English Applications > Health and care > Prevention, English Applications > Health and care > Treatment, Objectifs de Développement Durable > ODD 03 : Bonne santé et bien-être, Sustainable Development Goals > Goal 03: Good Health and Well-Being
Personalized Medicine Using Additive Manufacturing
THE CHALLENGE A major problem posed by the pharmaceutical industry is giving effective dosages while not giving excessive amounts of a particular drug. An estimated 80% of side effects in humans and animals are a direct result of inaccurate dosing because varying weights in patients. Additive manufacturing has emerged as a very promising method to...
Published: 6/26/2025   |   Inventor(s): Emily Wilts, Timothy Long, Christopher Williams, Da Ma
Keywords(s):  
Category(s): Technology Classifications > Additive Manufacturing, Technology Classifications > Biomedical, Technology Classifications > Chemicals/Materials, Technology Classifications > Pharmacology and Therapeutics
Use of Vitronectin as a Biomarker for the Detection of Dengue Hemorrhagic Fever
Dengue hemorrhagic fever (DHF) is a severe, potentially deadly infection spread by mosquitos. CDC scientists have identified vitronectin as an important biomarker of DHF. They have shown vitronectin is significantly reduced in DHF and severe dengue infections when compared to dengue non-hemorrhagic fever patients. Presently, DHF is established by assessing...
Published: 4/24/2025   |   Inventor(s): Momar Ndao, Kay Tomashek, Betty Poole-Smith, Elizabeth Hunsperger
Keywords(s): assay, Biomarker, DA4BXX, DA4XXX, DAXXXX, DENGUE, Detection, diagnostic, DIFFERENTIATION, DXXXXX, FEVER, HEMORRHAGIC, HOST, UB1XXX
Category(s): Collaboration Sought > Licensing, Application > Diagnostics, TherapeuticArea > Infectious Disease, TherapeuticArea > Rare/Neglected Diseases